AUS
NZ
UK
CA
USA
IND
Highlights
- nib Holdings Ltd forecasts a $10 million loss for the first half of 2025 due to increased claims in New Zealand.
- The Australian division continues strong growth, offsetting some of the impact from NZ.
- CEO Mark Fitzgibbon anticipates improved performance in the second half of 2025.
nib Holdings Ltd (ASX:NHF), a prominent health and medical insurance provider, has announced a projected $10 million operating loss for the first half of 2025. This outcome is largely attributed to a surge in insurance claims within the New Zealand market, which has impacted the company’s overall commercial performance despite the steady growth observed in its Australian operations.
The company recently provided guidance for its underlying operating profit (UOP) for the fiscal year 2025, estimating it to range between AUD$235 million and AUD$250 million. While nib's flagship Australian Resident Health Insurance (arhi) business continues to grow robustly, the increase in New Zealand claims has presented significant challenges, adding pressure to the company’s group-level results. CEO and managing director Mark Fitzgibbon emphasized that claim inflation in New Zealand remains a substantial factor contributing to this decline.
Fitzgibbon highlighted nib’s Australian sector as a bright spot, revealing that net policyholder growth within arhi has surged by over 52% in the first four months of this year, compared to the same period last year. With an annualized growth rate of 3.2%, this division is anticipated to outperform the average market growth. Fitzgibbon also noted that nib expects its net margin for the fiscal year to fall within its target range of 6.0% to 7.0%, adding some resilience to the company's financial outlook.
The CEO further elaborated on the situation, mentioning that the heightened claims experience in New Zealand has led to an anticipated operating loss of around AUD$10 million in the first half of FY25. However, he remains optimistic that the second half of the year may yield better results. Cost-management initiatives, including potential price adjustments and operating expense reductions, are expected to help stabilize nib's overall performance as claims inflation moderates.
Looking ahead, Fitzgibbon suggested that while full-year profitability remains achievable, it may fall short of fiscal year 2024's performance. Following this update, nib’s shares experienced a minor decline, trading at $5.99 with a 0.08% dip as of 11:59 AEDT.
This forecasted performance highlights the balancing act nib faces, with its Australian segment demonstrating strength while its New Zealand operations grapple with elevated claims. Investors will likely be watching closely to see if nib’s cost-saving measures and strategic adjustments in New Zealand contribute to the anticipated improvement in the second half of FY25.
